Janus kinase inhibitor overcomes resistance to immune checkpoint inhibitor treatment in peritoneal dissemination of gastric cancer in C57BL/6 J mice Wan-Ying DuHiroki MasudaSachiyo Nomura Original Article Open access 28 May 2024
CTNND1 is involved in germline predisposition to early-onset gastric cancer by affecting cell-to-cell interactions Cristina Herrera-ParienteLaia BonjochLeticia Moreira Original Article Open access 25 May 2024
A machine learning model for predicting the lymph node metastasis of early gastric cancer not meeting the endoscopic curability criteria Minoru KatoYoshito HayashiTetsuo Takehara Original Article Open access 25 May 2024
YAP inhibition overcomes adaptive resistance in HER2-positive gastric cancer treated with trastuzumab via the AKT/mTOR and ERK/mTOR axis Jiao QiaoMei FengLiyan Cui Original Article Open access 23 May 2024
Factors associated with the efficacy of first-line nivolumab plus chemotherapy in advanced gastric cancer patients with deficient mismatch repair Young-Gyu ParkHyung-Don KimMin-Hee Ryu Original Article 23 May 2024
SMARCA4-deficient undifferentiated gastric carcinoma: a case series and literature review Hyeong Rok AnHyung-Don KimYoung Soo Park Case Report 22 May 2024
Development of a reliable surgical quality assurance tool for gastrectomy in oncological trials A. HarrisJ. B. ButterworthG. B. Hanna Original Article Open access 18 May 2024
Early gastric cancer with RhoGAP fusion is linked to frequent nodal metastasis and a part of microtubular–mucocellular histology Hiroto NodaSeiji SakataHiroshi Kawachi Original Article 16 May 2024
Molecular features and prognostic factors of locally advanced microsatellite instability-high gastric cancer Kenichiro FurukawaKeiichi HatakeyamaKen Yamaguchi Original Article 14 May 2024
Claudin-18 status and its correlation with HER2 and PD-L1 expression in gastric cancer with peritoneal dissemination Haruki OgawaHiroyuki AbeTetsuo Ushiku Original Article Open access 09 May 2024
Adjuvant and post-recurrent treatment patterns in patients with resectable gastric cancer in japan: a retrospective database cohort study Takaki YoshikawaYorifumi KikkoShuichi Hironaka Original Article Open access 30 April 2024
Revisiting the use of the EORTC QLQ-STO22 to assess health-related quality of life of patients with gastric cancer: incorporating updated treatment options and cross-cultural perspectives S. C. SodergrenA. Hurley-WallaceOn behalf of the EORTC Quality of Life Group Original Article Open access 26 April 2024
Identification of maximal tumor size associated with negligible lymph node metastasis for endoscopic submucosal dissection of undifferentiated-type early gastric cancer Sung Eun OhSoomin AhnJi Yeong An Original Article 25 April 2024
Discordant PD-L1 results between 28–8 and 22C3 assays are associated with outcomes of gastric cancer patients treated with nivolumab plus chemotherapy Hyung-Don KimJinho ShinYoung Soo Park Original Article 22 April 2024
Family history and gastric cancer incidence and mortality in Asia: a pooled analysis of more than half a million participants Dan HuangMinkyo SongDaehee Kang Original Article Open access 22 April 2024
Feasibility of intraoperative pathologic examination for sentinel lymph nodes during sentinel node navigation surgery in early gastric cancer: results of pathologic protocol for SENORITA trial Sin Hye ParkSoo Young ChungMyeong-Cherl Kook Original Article 22 April 2024
International consensus on the management of metastatic gastric cancer: step by step in the foggy landscape Paolo MorgagniMaria BencivengaGiovanni de Manzoni Original Article Open access 18 April 2024
Adding salt to food at table as an indicator of gastric cancer risk among adults: a prospective study Selma Kronsteiner-GicevicAlysha S. ThompsonTilman Kühn Original Article Open access 17 April 2024
Letter to the editor: 5-year follow-up results of a JCOG1104 (OPAS-1) phase III non-inferiority trial to compare 4 courses and 8 courses of S-1 adjuvant chemotherapy for pathological stage II gastric cancer Hyung-Don KimMin-Hee RyuYoon-Koo Kang Letter to the Editor 11 April 2024
Genome-wide 5-hydroxymethylcytosines in circulating cell-free DNA as noninvasive diagnostic markers for gastric cancer Yingli FuJing JiangXueyuan Cao Original Article 07 April 2024
Precise highlighting of the pancreas by semantic segmentation during robot-assisted gastrectomy: visual assistance with artificial intelligence for surgeons Tatsuro NakamuraNao KobayashiHisashi Shinohara Original Article 04 April 2024
Global burden of young-onset gastric cancer: a systematic trend analysis of the global burden of disease study 2019 Yunhao LiAnne I. HahnWai K. Leung Original Article Open access 03 April 2024
Risk prediction model for gastric cancer within 5 years in healthy Korean adults Hyungseok OhSunwoo ChoYoosoo Chang Original Article 01 April 2024
Prognostic value of mismatch repair deficiency in patients receiving first-line fluoropyrimidine plus platinum for metastatic, recurrent, or unresectable gastric cancer Chung Ryul OhEo Jin KimYoon-Koo Kang Original Article 31 March 2024
Correction: Ubiquitous mitochondrial creatine kinase promotes the progression of gastric cancer through a JNK-MAPK/JUN/HK2 axis regulated glycolysis Yushuai MiQuanhui LiYinlu Ding Correction Open access 22 March 2024 Pages: 646 - 648
Correction: Resistance to FGFR1-targeted therapy leads to autophagy via TAK1/AMPK activation in gastric cancer Rui PengYan ChenYun Chen Correction 21 March 2024 Pages: 643 - 645
Superior lymph node harvest by fluorescent lymphography during minimally invasive gastrectomy for gastric cancer patients with high body mass index Ki-Yoon KimJawon HwangWoo Jin Hyung Original Article 19 March 2024 Pages: 622 - 634
Ethnic‑specific associations between body mass index and gastric cancer: a Mendelian randomization study in European and Korean populations Zhe WangDa LiCheng Zhang Letter to the Editor 18 March 2024 Pages: 641 - 642
Adjuvant treatment for locally advanced gastric cancer: an Asian perspective Hyung-Don KimMin-Hee RyuYoon-Koo Kang Review Article 15 March 2024 Pages: 439 - 450
Specific lineage transition of tumor-associated macrophages elicits immune evasion of ascitic tumor cells in gastric cancer with peritoneal metastasis Yilin LiLei JiangLin Shen Original Article Open access 09 March 2024 Pages: 519 - 538
Perioperative chemotherapy with docetaxel plus oxaliplatin and S-1 (DOS) versus oxaliplatin plus S-1 (SOX) for the treatment of locally advanced gastric or gastro-esophageal junction adenocarcinoma (MATCH): an open-label, randomized, phase 2 clinical trial Zhichao JiangYibin XieAiping Zhou Original Article Open access 08 March 2024 Pages: 571 - 579
Clinicopathological significance of microsatellite instability and immune escape mechanism in patients with gastric solid-type poorly differentiated adenocarcinoma Shinya UmekitaDaisuke KiyozawaYoshinao Oda Original Article 05 March 2024 Pages: 484 - 494
Patient metabolic profile defined by liver and muscle 18F-FDG PET avidity is independently associated with overall survival in gastric cancer Gerardo A. VitielloVetri Sudar JayaprakasamVivian E. Strong Original Article 04 March 2024 Pages: 548 - 557
Dietary intake of vitamin C and gastric cancer: a pooled analysis within the Stomach cancer Pooling (StoP) Project Michele SassanoMonireh Sadat SeyyedsalehiPaolo Boffetta Original Article Open access 04 March 2024 Pages: 461 - 472
Racial disparities of gastric cancer in the USA: an overview of epidemiology, global screening guidelines, and targeted screening in a heterogeneous population Jean Woo MokYeong Ha OhSekhar Padmanabhan Review Article 04 March 2024 Pages: 426 - 438
Statin use in relation to long-term survival after gastrectomy for gastric adenocarcinoma: a Swedish population-based cohort study Dag HolmbergJoonas H. KauppilaJesper Lagergren Original Article Open access 02 March 2024 Pages: 590 - 597
Discrepant effect of high-density lipoprotein cholesterol on esophageal and gastric cancer risk in a nationwide cohort Su Youn NamJunwoo JoSeong Woo Jeon Original Article 28 February 2024 Pages: 451 - 460
Gastric fundic gland polyposis and cancer development after eradication of Helicobacter pylori in patient with gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS) Koichi OkamotoTomoyuki KawaguchiTetsuji Takayama Case Report 26 February 2024 Pages: 635 - 640
Impact of preoperative prealbumin levels on long-term prognosis in patients with gastric cancer after gastrectomy: a retrospective cohort study Ryota MatsuiSatoshi IdaSouya Nunobe Original Article 24 February 2024 Pages: 611 - 621
Killer cell lectin-like receptor G2 facilitates aggressive phenotypes of gastric cancer cells via dual activation of the ERK1/2 and JAK/STAT pathways Yuki ItoMitsuro KandaYasuhiro Kodera Original Article 22 February 2024 Pages: 506 - 518
Elucidating molecular mechanisms and therapeutic synergy: irreversible HER2-TKI plus T-Dxd for enhanced anti-HER2 treatment of gastric cancer Jiankun LiuTienian ZhuJingpu Liu Original Article Open access 22 February 2024 Pages: 495 - 505
Clinical practice guidelines for esophagogastric junction cancer: Upper GI Oncology Summit 2023 Yuko KitagawaSatoru MatsudaTakeshi Sano Special Article Open access 22 February 2024 Pages: 401 - 425
Long-term oncological outcomes of 3D versus 2D laparoscopic gastrectomy for gastric cancer: a randomized clinical trial Qing ZhongJun-Yu ChenChao-Hui Zheng Original Article 20 February 2024 Pages: 598 - 610
Sustained exposure to Helicobacter pylori induces immune tolerance by desensitizing TLR6 Xiulin ZhangYang HeChanglong Li Original Article Open access 04 February 2024 Pages: 324 - 342
Bemarituzumab as first-line treatment for locally advanced or metastatic gastric/gastroesophageal junction adenocarcinoma: final analysis of the randomized phase 2 FIGHT trial Zev A. WainbergYoon-Koo KangPeter C. Enzinger Original Article Open access 03 February 2024 Pages: 558 - 570
Rivoceranib, a VEGFR-2 inhibitor, monotherapy in previously treated patients with advanced or metastatic gastric or gastroesophageal junction cancer (ANGEL study): an international, randomized, placebo-controlled, phase 3 trial Yoon-Koo KangMin-Hee RyuNarikazu Boku Original Article Open access 28 January 2024 Pages: 375 - 386
Inhibition of proprotein convertases activity results in repressed stemness and invasiveness of cancer stem cells in gastric cancer Anissa ZaafourLornella SeeneevassenChristine Varon Original Article 27 January 2024 Pages: 292 - 307
Chromosomal copy number amplification-driven Linc01711 contributes to gastric cancer progression through histone modification-mediated reprogramming of cholesterol metabolism Ben YueJianjun ChenChunchao Zhu Original Article 25 January 2024 Pages: 308 - 323
Biological and targeting differences between the rare KRAS A146T and canonical KRAS mutants in gastric cancer models Elisabetta PuligaChiara De BellisSilvia Giordano Original Article Open access 23 January 2024 Pages: 473 - 483
